Roche Ordered to Pay $18 Million to Former Accutane Users

Roche Holding AG must pay a total of $18 million in damages to two former users of its Accutane acne drug who blamed the medicine for their bowel disease, a New Jersey jury ruled.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.